Omarigliptin/rosinidin combination ameliorates cyclophosphamide-induced lung toxicity in rats: The interaction between glucagon-like peptide-1, TXNIP/NLRP3 inflammasome signaling, and PI3K/Akt/FoxO1 axis.

MLA

Abd Elmaaboud, Maaly A., et al. “Omarigliptin/Rosinidin Combination Ameliorates Cyclophosphamide-Induced Lung Toxicity in Rats: The Interaction between Glucagon-like Peptide-1, TXNIP/NLRP3 Inflammasome Signaling, and PI3K/Akt/FoxO1 Axis.” Biomedicine & Pharmacotherapy, vol. 177, Aug. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.117026.

APA

Abd Elmaaboud, M. A., Kabel, A. M., Borg, H. M., Magdy, A. A., Kabel, S. M., Arafa, E.-S. A., Alsufyani, S. E., & Arab, H. H. (2024). Omarigliptin/rosinidin combination ameliorates cyclophosphamide-induced lung toxicity in rats: The interaction between glucagon-like peptide-1, TXNIP/NLRP3 inflammasome signaling, and PI3K/Akt/FoxO1 axis. Biomedicine & Pharmacotherapy, 177, N.PAG. https://doi.org/10.1016/j.biopha.2024.117026

Chicago

Abd Elmaaboud, Maaly A., Ahmed M. Kabel, Hany M. Borg, Amr A. Magdy, Shaimaa M. Kabel, El-Shaimaa A. Arafa, Shuruq E. Alsufyani, and Hany H. Arab. 2024. “Omarigliptin/Rosinidin Combination Ameliorates Cyclophosphamide-Induced Lung Toxicity in Rats: The Interaction between Glucagon-like Peptide-1, TXNIP/NLRP3 Inflammasome Signaling, and PI3K/Akt/FoxO1 Axis.” Biomedicine & Pharmacotherapy 177 (August): N.PAG. doi:10.1016/j.biopha.2024.117026.